AkiSens Competitors

UC San Francisco is driven by the idea that when the best research, the best education and the best patient care converge, great breakthroughs are achieved. We pursue this integrated excellence with singular focus, fueled by collaboration among our top-ranked professional and graduate schools, medical center, research programs and support teams.

Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care. We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges. GRAIL is headquartered in Sunnyvale, California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. For more information, please visit grail.com. Community Guidelines: https://bit.ly/3xigb24

For 15 years, Omada Health has been in the corner of millions of Americans managing chronic conditions. We help our members between doctor visits, providing virtual care that adapts to real life. We partner with employers, health plans, pharmacy benefit managers, and government agencies to support their populations across common chronic conditions — from prediabetes, diabetes, and hypertension to muscle and joint pain— all through the convenience of an app. Our programs also adapt to provide specialized care for GLP-1 journeys. At Omada, care isn’t built for perfection. It’s built for real people. Our clinically-validated programs combine human connection with modern technology, pairing members with real coaches and care teams. Omada’s impact is proven: our outcomes are published in 30 peer-reviewed studies, showing lasting behavior change, reduced healthcare costs, and ROI for our partners. Our success starts with our people. Omada’s strong, inclusive culture has earned us the Great Place to Work certification, and in 2025 we became a Nasdaq-listed company — a milestone on our mission to bend the curve of chronic disease.